143 Mesothelin (MSLN) targeting allogeneic CAR T cells engineered to overcome tumor immunosuppressive microenvironment by Agnes Gouble, Roman Galetto, Cécile Schiffer-Mannioui, Sophie Leduc, Isabelle Chion-Sotinel, Diane le Clerre, Valérie Guyot, Marco Rotondi